Voyageur Pharmaceuticals Stock Price, News & Analysis (CVE:VM) C$0.04 -0.01 (-12.50%) (As of 12/1/2023 05:23 PM ET) Add Compare Share Share Today's RangeC$0.04▼C$0.0450-Day RangeC$0.04▼C$0.0552-Week RangeC$0.04▼C$0.11Volume2,000 shsAverage Volume110,762 shsMarket CapitalizationC$4.64 millionP/E RatioN/ADividend YieldN/APrice TargetN/A Stock AnalysisStock AnalysisChartHeadlinesStock AnalysisChartHeadlines About Voyageur Pharmaceuticals Stock (CVE:VM)Voyageur Pharmaceuticals Ltd., together with its subsidiaries, engages in the acquiring, exploring, and developing raw materials for pharmaceutical products, primarily in the province of British Columbia, Canada, and the state of Utah. The company develops barium and iodine-based APIs. The company was formerly known as Voyageur Minerals Ltd. and changed its name to Voyageur Pharmaceuticals Ltd. in December 2019. Voyageur Pharmaceuticals Ltd. was founded in 2017 and is headquartered in Calgary, Canada.Read More VM Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart VM Stock News HeadlinesOctober 24, 2023 | theglobeandmail.comClosing Bell: Voyageur Pharmaceuticals Ltd up on Monday (VM)September 14, 2023 | stockhouse.comVoyageur Pharmaceuticals Achieves Milestone in the Development of HDXBa Barium Contrast MediaDecember 3, 2023 | DTI Trader (Ad)New CBOE “special perk” helps traders target income every weekendYou might not immediately realize what you’re reading. Let me help you out a little… What you're looking at is a “special perk” set up by the Chicago Board of Options Exchange. September 14, 2023 | proactiveinvestors.comVoyageur Pharmaceuticals achieves milestone developing HDXBa barium contrast mediaSeptember 7, 2023 | theglobeandmail.comClosing Bell: Voyageur Pharmaceuticals Ltd up on Wednesday (VM)June 20, 2023 | theglobeandmail.comClosing Bell: Voyageur Pharmaceuticals Ltd down on Tuesday (VM)May 31, 2023 | proactiveinvestors.comVoyageur Pharmaceuticals completes field work at Frances Creek project in British ColumbiaMay 24, 2023 | finance.yahoo.comVoyageur Pharmaceuticals Partners with Rain Cage Carbon to Revolutionize Medical Imaging with Nanocarbon-Based Contrast DrugsDecember 3, 2023 | DTI Trader (Ad)All the trading advice you’ve ever received boils down to thisAll the trading advice you’ve ever received boils down to one goal and one goal only: finding a reliable edge in the markets. If you can do that, grab hold of it and never let go. Because once you have that edge, and you can count on it, you never need to do anything else.May 24, 2023 | proactiveinvestors.comVoyageur Pharmaceuticals unveils pioneering agreement with Rain Cage CarbonMay 10, 2023 | theglobeandmail.comClosing Bell: Voyageur Pharmaceuticals Ltd flat on Tuesday (VM)May 4, 2023 | theglobeandmail.comClosing Bell: Voyageur Pharmaceuticals Ltd flat on Wednesday (VM)May 2, 2023 | theglobeandmail.comClosing Bell: Voyageur Pharmaceuticals Ltd down on Monday (VM)April 29, 2023 | theglobeandmail.comClosing Bell: Voyageur Pharmaceuticals Ltd up on Friday (VM)April 28, 2023 | theglobeandmail.comClosing Bell: Voyageur Pharmaceuticals Ltd flat on Thursday (VM)April 26, 2023 | theglobeandmail.comClosing Bell: Voyageur Pharmaceuticals Ltd flat on Monday (VM)April 22, 2023 | theglobeandmail.comClosing Bell: Voyageur Pharmaceuticals Ltd flat on Friday (VM)April 21, 2023 | theglobeandmail.comClosing Bell: Voyageur Pharmaceuticals Ltd down on Thursday (VM)April 14, 2023 | theglobeandmail.comClosing Bell: Voyageur Pharmaceuticals Ltd down on Friday (VM)April 8, 2023 | theglobeandmail.comClosing Bell: Voyageur Pharmaceuticals Ltd down on Wednesday (VM)April 6, 2023 | theglobeandmail.comClosing Bell: Voyageur Pharmaceuticals Ltd up on Tuesday (VM)April 4, 2023 | proactiveinvestors.comVoyageur Pharmaceuticals reports positive comparative study of SmoothX barium contrast media for CT imagingFebruary 14, 2023 | proactiveinvestors.comVoyageur Pharmaceuticals preparing to launch sales of its first product in CanadaFebruary 10, 2023 | finance.yahoo.comVoyageur Pharmaceuticals Ltd. (VM.V)January 23, 2023 | proactiveinvestors.comVoyageur Pharmaceuticals completes second and final closing of its private placement for gross proceeds of $1,019,953.53December 8, 2022 | proactiveinvestors.comVoyageur Pharmaceuticals launches SmoothX barium contrast media in CanadaDecember 5, 2022 | proactiveinvestors.comVoyageur Pharmaceuticals issues deferred share units to directors under equity incentive compensation planSee More Headlines Receive VM Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Voyageur Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. Email Address Industry, Sector and Symbol Stock ExchangeCVE Industry Drug Manufacturers - Specialty & Generic Sub-IndustryN/A SectorMedical Current SymbolCVE:VM CUSIPN/A CIKN/A Webwww.voyageurminerals.ca Phone587-779-6166FaxN/AEmployeesN/AYear FoundedN/AProfitability EPS (Most Recent Fiscal Year)C($0.02) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet IncomeC$-1,690,000.00 Net MarginsN/A Pretax MarginN/A Return on Equity-92.31% Return on Assets-40.67% Debt Debt-to-Equity Ratio1.49 Current Ratio0.22 Quick Ratio0.84 Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowC$0.00 per share Price / Cash Flow35.00 Book ValueC$0.01 per share Price / Book3.50Miscellaneous Outstanding Shares132,700,000Free FloatN/AMarket CapC$4.64 million OptionableNot Optionable Beta0.69 10 Best Stocks to Own in 2024Click the link below and we'll send you MarketBeat's list of the 10 best stocks to own in 2024 and why they should be in your portfolio. Get This Free Report Key ExecutivesMr. Brent Willis Bsc.Eng (Age 52)President, CEO & Director Comp: $131kMr. Bradley Craig Willis P.Eng. (Age 52)Founder, COO & Director Comp: $125.5kMr. Albert DeslauriersChief Financial OfficerKey CompetitorsDelta 9 CannabisTSE:DNLattice BiologicsCVE:LBLAequus PharmaceuticalsCVE:AQSEntourage HealthCVE:ENTGHarvest One CannabisCVE:HVTView All Competitors VM Stock Analysis - Frequently Asked Questions How have VM shares performed in 2023? Voyageur Pharmaceuticals' stock was trading at C$0.09 on January 1st, 2023. Since then, VM shares have decreased by 58.8% and is now trading at C$0.04. View the best growth stocks for 2023 here. What other stocks do shareholders of Voyageur Pharmaceuticals own? Based on aggregate information from My MarketBeat watchlists, some companies that other Voyageur Pharmaceuticals investors own include Agile Therapeutics (AGRX), Sierra Oncology (SRRA), Achillion Pharmaceuticals (ACHN), LINE (LN), Littelfuse (LFUS), Howard Hughes (HHC), EQT (EQT), Deckers Outdoor (DECK), Cranswick (CWK) and Cirrus Logic (CRUS). How do I buy shares of Voyageur Pharmaceuticals? Shares of VM stock and other Canadian stocks can be purchased through an online brokerage account. Popular online brokerages with access to the Canadian stock market include BMO InvestorLine, CIBC Investor's Edge, Desjardins Online Brokerage, HSBC InvestDirect, Laurentian Bank Discount Brokerage, National Bank Direct Brokerage, Qtrade Investor, Questrade, RBC Direct Investing, Scotia iTrade, TD Direct Investing, and Virtual Brokers.Compare Top Brokerages Here. This page (CVE:VM) was last updated on 12/3/2023 by MarketBeat.com Staff Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Voyageur Pharmaceuticals Ltd. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.